Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells

Nature Immunology

Volumn 14, Issue 5, 2013, Pages 514-522

  Bermejo, Daniela A ^a   Jackson, Shaun W ^b,c   Gorosito Serran, Melisa ^a   Acosta Rodriguez, Eva V ^a   Amezcua Vesely, Maria Carolina ^a   Sather, Blythe D ^b,c   Singh, Akhilesh K ^b,c   Khim, Socheath ^b,c   Mucci, Juan ^d   Liggitt, Denny ^b   Campetella, Oscar ^d   Oukka, Mohamed ^b,c   Gruppi, Adriana ^a   Rawlings, David J ^b,c  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CD45 ANTIGEN; GLYCOCONJUGATE; INTERLEUKIN 17; INTERLEUKIN 17F; MUCIN; PROTEIN TYROSINE KINASE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SIALIDASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AHR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; TH17 CELL; TRANS ISOMER; TRANSCRIPTION REGULATION; TRYPANOSOMA CRUZI;

EID: 84876532051     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2569     Document Type: Article

References (54)

1. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
2. Gaffen, S.L. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23, 613-619 (2011).
3. Kelly, M.N. et al. Interleukin-17interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73, 617-621 (2005).
4. Pitta, M.G. et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 119, 2379-2387 (2009).
5. Rudner, X.L., Happel, K.I., Young, E.A. & Shellito, J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75, 3055-3061 (2007).
6. da Matta Guedes, P.M. et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl. Trop. Dis. 4, e604 (2010).
7. Miyazaki, Y. et al. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J. Immunol. 185, 1150-1157 (2010).
8. Mou, Z., Jia, P., Kuriakose, S., Khadem, F. & Uzonna, J.E. Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice. Infect. Immun. 78, 5271-5279 (2010).
9. Tosello Boari, J. et al. IL-17RA signaling reduces infammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog. 8, e1002658 (2012).
10. Cua, D.J. & Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010).
11. Bryan, M.A., Guyach, S.E. & Norris, K.A. Specifc humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. PLoS Negl. Trop. Dis. 4, e733 (2010).
12. Bermejo, D.A. et al. Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specifc antibodies. Immunology 132, 123-133 (2011).
13. Noelle, R.J., Ledbetter, J.A. & Aruffo, A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13, 431-433 (1992).
14. Meyer-Bahlburg, A. & Rawlings, D.J. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front. Biosci. 17, 1499-1516 (2012).
15. Rawlings, D.J., Schwartz, M.A., Jackson, S.W. & Meyer-Bahlburg, A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12, 282-294 (2012).
16. Tarleton, R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19, 430-434 (2007).
17. -T cells in the polyclonal lymphocyte responses to murine T. cruzi infection. Int. Immunol. 1, 176-184 (1989).
18. Bermejo, D.A. et al. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. PLoS Negl. Trop. Dis. 4, e679 (2010).
19. Schenkman, S., Eichinger, D., Pereira, M.E. & Nussenzweig, V. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48, 499-523 (1994).
20. Gao, W., Wortis, H.H. & Pereira, M.A. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specifc Ig secretion. Int. Immunol. 14, 299-308 (2002).
21. Alvarez, P., Leguizamon, M.S., Buscaglia, C.A., Pitcovsky, T.A. & Campetella, O. Multiple overlapping epitopes in the repetitive unit of the shed acute-phase antigen from Trypanosoma cruzi enhance its immunogenic properties. Infect. Immun. 69, 7946-7949 (2001).
22. Risso, M.G., Pitcovsky, T.A., Caccuri, R.L., Campetella, O. & Leguizamon, M.S. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections. Parasitology 134, 503-510 (2007).
23. Leguizamón, M.S., Mocetti, E., Garcia Rivello, H., Argibay, P. & Campetella, O. Trans.-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 180, 1398-1402 (1999).
24. Buschiazzo, A. et al. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structurefunction studies towards the rational design of inhibitors. PLoS Pathog. 8, e1002474 (2012).
25. Muiá, R.P. et al. Identifcation of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation. Glycobiology 20, 833-842 (2010).
26. Mucci, J., Risso, M.G., Leguizamon, M.S., Frasch, A.C. & Campetella, O. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation. Cell. Microbiol. 8, 1086-1095 (2006).
27. Kaneko, Y., Nimmerjahn, F. & Ravetch, J.V. Anti-infammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673 (2006).
28. Kuijf, M.L. et al. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J. Immunol. 185, 748-755 (2010).
29. Rabinovich, G.A. & Toscano, M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and infammation. Nat. Rev. Immunol. 9, 338-352 (2009).
30. Earl, L.A. & Baum, L.G. CD45 glycosylation controls T-cell life and death. Immunol. Cell Biol. 86, 608-615 (2008).
31. Zuñiga, E., Rabinovich, G.A., Iglesias, M.M. & Gruppi, A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J. Leukoc. Biol. 70, 73-79 (2001).
32. Acosta-Rodríguez, E.V. et al. Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. J. Immunol. 172, 493-502 (2004).
33. Gao, W. & Pereira, M.A. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase. Eur. J. Immunol. 31, 1503-1512 (2001).
34. Rawlings, D.J., Sommer, K. & Moreno-Garcia, M.E. The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol. 6, 799-812 (2006).
35. Moreno-García, M.E., Sommer, K.M., Bandaranayake, A.D. & Rawlings, D.J. Proximal signals controlling B-cell antigen receptor (BCR) mediated NF-KB activation. Adv. Exp. Med. Biol. 584, 89-106 (2006).
36. Dong, C. Genetic controls of Th17 cell differentiation and plasticity. Exp. Mol. Med. 43, 1-6 (2011).
37. Esser, C, Rannug, A. & Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454 (2009).
38. Eberl, G. & Littman, D.R. Thymic origin of intestinal aß T cells revealed by fate mapping of RORgammat+ cells. Science 305, 248-251 (2004).
39. He, Y.W., Deftos, M.L., Ojala, E.W. & Bevan, M.J. RORyt, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9, 797-806 (1998).
40. Hermiston, M.L., Xu, Z. & Weiss, A. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21, 107-137 (2003).
41. Hernandez, J.D., Klein, J., Van Dyken, S.J., Marth, J.D. & Baum, L.G. T-cell activation results in microheterogeneous changes in glycosylation of CD45. Int. Immunol. 19, 847-856 (2007).
42. Andrews, S.F. & Rawlings, D.J. Transitional B cells exhibit a B cell receptor-specifc nuclear defect in gene transcription. J. Immunol. 182, 2868-2878 (2009).
43. Rawlings, D.J. et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271, 822-825 (1996).
44. Rawlings, D.J. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin. Immunol. 91, 243-253 (1999).
45. Li, L. et al. IL-17 produced by neutrophils regulates IFN-y-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120, 331-342 (2010).
46. Yu, H. et al. A multifunctional Pasteurella multocida sialyltransferase: a powerful tool for the synthesis of sialoside libraries. J. Am. Chem. Soc. 127, 17618-17619 (2005).
47. Cheng, J. et al. Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities. Glycobiology 18, 686-697 (2008).
48. Gut, H., King, S.J. & Walsh, M.A. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: An intramolecular trans-sialidase. FEBS Lett. 582, 3348-3352 (2008).
49. Cheng, J. et al. Trans.-sialidase activity of Photobacterium damsela a2, 6-sialyltransferase and its application in the synthesis of sialosides. Glycobiology 20, 260-268 (2010).
50. Gutierrez, F.R., Guedes, P.M., Gazzinelli, R.T. & Silva, J.S. The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol. 31, 673-685 (2009).
51. Norris, K.A., Schrimpf, J.E. & Szabo, M.J. Identifcation of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein. Infect. Immun. 65, 349-357 (1997).
52. Campetella, O.E., Uttaro, A.D., Parodi, A.J. & Frasch, A.C. A recombinant Trypanosoma cruzi trans-sialidase lacking the amino acid repeats retains the enzymatic activity. Mol. Biochem. Parasitol. 64, 337-340 (1994).
53. H17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472, 491-494 (2011).
54. -ΔΔCTmethod. Methods 25, 402-408 (2001).